Cargando…

Dupilumab modulates specific IgE mite responses at the molecular level in severe T2-high atopic dermatitis: A real-world experience

BACKGROUND: Atopic dermatitis (AD) is regarded as a chronic systemic disease which is characterized by a robust overexpression of type 2 related cytokines, with increased total IgE levels and a concomitant sensitization to common allergens. Dupilumab, a fully human monoclonal antibody (mAb) to IL-4R...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Pérez, Ruperto, Poza-Guedes, Paloma, Mederos-Luis, Elena, Sánchez-Machín, Inmaculada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411935/ https://www.ncbi.nlm.nih.gov/pubmed/36035412 http://dx.doi.org/10.3389/fmed.2022.939598

Ejemplares similares

House Dust Mite Precision Allergy Molecular Diagnosis (PAMD@) in the Th2-prone Atopic Dermatitis Endotype
por: González-Pérez, Ruperto, et al.
Publicado: (2021)

Role of specific IgE to β-lactoglobulin in the gastrointestinal phenotype of cow’s milk allergy
por: Poza-Guedes, Paloma, et al.
Publicado: (2016)

Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype
por: González-Pérez, Ruperto, et al.
Publicado: (2022)

Safety of a dust mite extract in severe allergic asthma
por: González-Pérez, Ruperto, et al.
Publicado: (2013)

Role of Predatory Mites in Persistent Nonoccupational Allergic Rhinitis
por: Poza Guedes, Paloma, et al.
Publicado: (2016)

Storage Mite Precision Allergy Molecular Diagnosis in the Moderate-to-Severe T2-High Asthma Phenotype
por: González-Pérez, Ruperto, et al.
Publicado: (2022)

Molecular Mapping of Allergen Exposome among Different Atopic Phenotypes
por: González-Pérez, Ruperto, et al.
Publicado: (2023)

Evaluation of major mite allergens from European standardized commercial extracts for in vivo diagnosis: addressing the need for precision medicine
por: González-Pérez, Ruperto, et al.
Publicado: (2019)

Downregulation of Angiogenesis Factors, VEGF and PDGF, after Rapid IgE Desensitization and Oral Immunotherapy in Children with Food Allergy
por: Poza-Guedes, Paloma, et al.
Publicado: (2014)

Management of a Immunotherapy Unit During the COVID-19 Outbreak: Building a Resilient Health Care System.
por: Sanchez-Machin, Inmaculada, et al.
Publicado: (2021)

Oral mite anaphylaxis by Thyreophagus entomophagus in a child: a case report
por: Iglesias-Souto, Javier, et al.
Publicado: (2009)

Dupilumab for atopic dermatitis
Publicado: (2019)

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
por: Lee, Dong Hun, et al.
Publicado: (2022)

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
por: Kamata, Masahiro, et al.
Publicado: (2021)

Immediate anaphylaxis after the ingestion of fig fruit (Ficus carica)
por: Gonzalez Perez, Ruperto, et al.
Publicado: (2015)

Oral cow’s milk immunotherapy: clinical and serological data in long-term follow up
por: Poza Guedes, Paloma, et al.
Publicado: (2015)

Cluster subcutaneous allergen immunotherapy as a sustainable practice towards net zero healthcare
por: Domínguez Estirado, Alicia, et al.
Publicado: (2023)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

The association between the level of specific IgE to molecular components of mites and the expression of CD23 molecule on B lymphocytes in atopic dermatitis patients treated or not treated with dupilumab—Pilot study
por: Čelakovská, Jarmila, et al.
Publicado: (2023)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

IgE-Selective Immunoadsorption for Severe Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
por: Zhou, Bingjing, et al.
Publicado: (2022)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
por: Jang, Dong Hyek, et al.
Publicado: (2020)

Relations between vitamin D3, total and specific IgE for house dust mites in atopic dermatitis patients
por: Ibrahim, Hassan M., et al.
Publicado: (2020)

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
por: Eichenfield, Lawrence F., et al.
Publicado: (2022)

Atopic dermatitis, HSV and IgE: clinical and laboratory relationship
por: Seba, Amanda
Publicado: (2015)

Levels of total serum IgE and specific IgE sensitization profile in patients with atopic dermatitis
por: Poleshuck, Rafael Teixeira Figueredo, et al.
Publicado: (2015)

Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients
por: Pfisterer, Karin, et al.
Publicado: (2023)

Perception and Experience of Dupilumab in Atopic Dermatitis: A Real-Life Study
por: Antoine, Léa, et al.
Publicado: (2023)

Accuracy in diagnosis of allergy to β-lactams
por: Iglesias-Souto, Javier, et al.
Publicado: (2012)

A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals
por: Barrios, Yvelise, et al.
Publicado: (2021)

The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals
por: Barrios, Yvelise, et al.
Publicado: (2021)

Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience
por: Stingeni, L., et al.
Publicado: (2022)

IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases?
por: Pellefigues, Christophe
Publicado: (2020)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4kdm973rqutod34le8ssh6f430